Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

Orbimed Advisors LLC reported a 10.30% stake in Corvus Pharmaceuticals, Inc. (Schedule 13D/A)

Event Jan 23, 2026 · Filed Jan 27, 2026

Orbimed Advisors LLC reported a 10.30% stake in Corvus Pharmaceuticals, Inc., 8,609,091 shares, with active intent on Jan 23, 2026. Filed Jan 27, 2026 (Schedule 13D/A).

Stake
10.30%
Shares
8,609,091
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC10.30%8,609,091
ORBIMED CAPITAL GP V LLC10.30%8,609,091

Source

View original at SEC

Related